Search

everythinglearnresearchcommunity

for

Search:↓

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Bupropion SR may help treat trichotillomania.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

An 11-year-old girl with Trichotillomania developed a large hairball in her stomach, treated with medication, therapy, and family education.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

A woman had temporary hair loss due to stress from a spinal cord injury.

Trichoscopy helps accurately diagnose temporal triangular alopecia.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

CTP-543 is generally safe for treating alopecia areata.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Dietetic-led cognitive-behavioral therapy may improve treatment for adults with ARFID.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.